Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
C2 Pharma
CAI
DPS Group
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Small Molecule
19 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Business Leadership
Olon Announces the Appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division
PR-M09-22-04
Drug Discovery
Enabling Seamless Workflows for Small Molecule Drug Discovery
PAO-08-022-CL-08
R&D Data Management
Dotmatics Launches Small Molecule Drug Discovery Solution Helping Researchers Accelerate Life-Improving Therapies
PR-M07-22-05
API
Small Molecule API Market Trends
PAO-06-022--NI-11
mRNA
The Intersection of mRNA Biology and Artificial Intelligence is Yielding Unique mRNA Drug Candidates
PAO-04-022-CL-14
Solubility
The Limitless Potential of Thin Film Freezing
PAO-01-22-CL-04
Oncology
Fighting Cancer by Focusing on Nuclear Export
PAO-02-022-CL-06
Parenteral Drugs
A CDMO Dedicated to Supporting Small-Volume, Small-Molecule Parenteral Projects
PAO-12-21-CL-02
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
PAO-09-21-CL-05
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
PAP-Q4-20-CL-025
Small Molecule API
Supporting Client Projects for CDMO Success
PAP-Q1-2019-CL-030
Oncology
Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors
PR-M11-18-NI-048
Designation
Prometic receives Rare Pediatric Disease Designation from U.S. FDA for small molecule drug candidate, PBI-4050
PR-M08-18-NI-068
Business
Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases
PR-M01-18-NI-009
NIH Funds Novel Small Molecule Approach to Interrupt Alzheimer’s Dementia
PAO-M10-17-NI-003
Innovation
New Technology Allows Imaging of Complex Molecular Processes
PAO-M06-17-NI-023
Growth Anticipated for Intermediates
PAP-Q1-17-FA-005
A New Industry Think Tank Forum for Leaders of Outsourced Services and Customers
PAP-Q04-16-NS-001
Growing Demand for Small-Molecule CDMO Services
PAP-Q1-16-CL-004
